|
|
||||||||
University of Michigan Medical School, Ann Arbor, Michigan
Correspondence: For reprints contact: R. E. Counsell, PhD, Dept. of Pharmacology, Univ. of Michigan Medical School, Ann Arbor, MI 48109.
ABSTRACT
This preliminary study was undertaken in order to explore possible methods for enhancing the target organ specificity of radioiodinated cholesterol. 19-[125I]cholesterol (I*C) was rapidly incorporated and transported in high-density lipoproteins (HDL) following i.v. administration to rats, and thus behaved like cholesterol in this regard. Incorporation of I*C into HDL (I*C-HDL) before administration produced little change in the tissue distribution profile except for a reduction in the amount of radioactivity appearing in the thyroid. This suggested that the lipoprotein carrier may have afforded protection from metabolic dehalogenation of I*C. When rats were pretreated with 4-aminopyrazolo-(3,4d)-pyrimidine to drastically reduce the circulating lipoprotein levels, a fourfold enhancement in adrenal uptake was observed following administration of I*C-HDL. This finding was consistent with the current view that the rat adrenal contains high-affinity and saturable receptors for HDL.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |